The bronchodilator effect of a new anticholinergic drug, Sch 1000.
D000281:Administration, Intranasal; D000328:Adult; D000368:Aged; D000402:Airway Obstruction / Q000150:complications; D000403:Airway Resistance / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001827:Body Height; D001835:Body Weight; D001916:Brachial Artery; D001965:Bromides / Q000627:therapeutic use*; D001991:Bronchitis / Q000150:complications; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000032:analysis; D002404:Catheterization; D004305:Dose-Response Relationship, Drug; D005260:Female; D006326:Heart Auscultation; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000494:pharmacology*; D008875:Middle Aged; D010100:Oxygen / Q000032:analysis; D010276:Parasympatholytics / Q000494:pharmacology*; D010993:Plethysmography, Whole Body; D011674:Pulse / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012129:Respiratory Function Tests; D014326:Tropanes / Q000494:pharmacology*; D014797:Vital Capacity / Q000187:drug effects
D001965:Bromides; D001993:Bronchodilator Agents; D010276:Parasympatholytics; D014326:Tropanes; D002245:Carbon Dioxide; D009921:Metaproterenol; D010100:Oxygen